# CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS

> **NCT06252402** · EARLY_PHASE1 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- HIV-1

## Interventions

- **BIOLOGICAL:** CMV/HIV-CAR T Cells

## Key facts

- **NCT ID:** NCT06252402
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2026-12-11
- **Final completion:** 2026-12-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06252402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06252402, "CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06252402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*